Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 924 of 5804
-
Could a common diabetes drug ease a type of heart failure?
Disease control CompletedThe main objective of this study is to determine the clinical efficacy of metformin versus placebo and the therapeutic response with regards to functional capacity and hemodynamics in PH-HFpEF.
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for mystery cancers: immunotherapy shows promise
Disease control CompletedAbbreviated Title : CUPem Clinical Indication : A Phase II, Two-Stage, Trial of Pembrolizumab in Cancer of unknown primary Trial Type : Single Arm, non-randomised; Two-stage; Hypothesis generating Type of control : None Route of administration : IV Trial Blinding : N/A Treatment…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can psoriasis patients skip more shots? new trial tests extended guselkumab dosing
Disease control CompletedThe purpose of this study is to demonstrate that Super-Responders (SRe; defined as psoriasis participants who receive on-label guselkumab treatment until week 20 and respond with a Psoriasis Area and Severity Index score (PASI) = 0 at weeks 20 and 28) maintain control of disease …
Phase: PHASE3 • Sponsor: Janssen-Cilag International NV • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors
Disease control OngoingThis is a single arm, phase II study without blinding. The purpose is to determine the impact of hepatic artery infusion Floxuridine (FUDR) on liver metastases from pancreatic adenocarcinoma. Patients at Spectrum Health will receive standard of care chemotherapy. They will also r…
Phase: PHASE2 • Sponsor: Corewell Health West • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can MRI outsmart blood tests for prostate cancer?
Diagnosis Recruiting nowThe commercialization of MRI fusion biopsies has resulted in a dramatic increase in the use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate biopsy setting given the availability of validated prostate cancer early detection markers is uncertain.This…
Sponsor: University of Michigan • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Can a vaccine keep TB away for good? new study tests H56:IC31
⭐️ VACCINE ⭐️ CompletedThis is a phase 2, double-blind, randomized (1:1), placebo-controlled trial with two parallel groups. * H56:IC31 (investigational vaccine) * Placebo 900 HIV-negative adults with a diagnosis of drug susceptible pulmonary TB are planned to be included, recruited from TB clinics…
Phase: PHASE2 • Sponsor: International AIDS Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:07 UTC
-
Blood test could help pick the right drug for tough colorectal cancers
Disease control OngoingThis phase II trial studies circulating cell-free tumor DNA testing to guide treatment with regorafenib or TAS-102 in patients with colorectal cancer that has spread to other areas of the body. Studying samples of blood from patients with colorectal cancer may help doctors unders…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Blood test may catch pelvic cancer relapse sooner
Diagnosis CompletedctDNA detection in patients with previously treated, HPV-induced, stage II or III invasive pelvic cancer and who are currently in post-treatment follow-up.
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a tailored antibiotic regimen shorten endocarditis treatment without risk?
Disease control OngoingExisting guidelines recommend a duration of antibiotic treatment of endocarditis of 4-6 weeks one or more types of intravenously administered antibiotics. The long hospitalization increases several risks for the patient, including mental strain and increased loss of function. Fur…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Gene therapy trial targets HIV and lymphoma together
Disease control CompletedThe purpose of this study is to evaluate the safety and the feasibility, and the success of engraftment of the introduction of Cal-1 gene-transduced haematopoietic cell populations (Ttn and HSPCtn) in patients with HIV-1-related high-risk lymphoma.
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Immune cells take on childhood cancer in early trial
Disease control OngoingThis NANT trial will determine the maximum tolerated dose (MTD) of autologous expanded natural killer (NK) cells when combined with standard dosing of dinutuximab and will assess the feasibility of adding lenalidomide at the recommended Phase II dose of the expanded NK cells with…
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Lifestyle overhaul may shield aging brains from memory loss
Prevention CompletedThe purpose of this research study is to see if lifestyle changes can protect memory and thinking (cognition) as we age. A recent study in Finland found that a combination of physical and cognitive exercise, diet, and social activity protected cognitive function in healthy older …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to find best myeloma treatment for seniors
Disease control OngoingMultiple myeloma (MM) is a neoplastic disease deriving from an abnormal proliferation of monoclonal plasma cells in the bone marrow. The survival of MM patients varies from less than 6 months to more than 10 years depending on the stage of disease at diagnosis and prognostic fact…
Phase: PHASE4 • Sponsor: University of Turin, Italy • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Liver cancer combo therapy fails to outperform standard drug
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of lenvatinib (E7080/MK-7902) in combination with pembrolizumab (MK-3745) versus lenvatinib in combination with placebo as first-line therapy for the treatment of advanced hepatocellular carcinoma in adult participa…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail of drugs shows promise for tough lung cancer
Disease control OngoingThis study is designed to determine the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non-Small Cell Lung Cancer (NSCLC)
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Tailored tumor attack: can custom drug cocktails beat recurrent glioblastoma?
Disease control CompletedThe current study will test the ability and likelihood of successfully implementing individualized combination treatment recommendations for adult patients with surgically-resectable recurrent glioblastoma in a timely fashion. Collected tumor tissue and blood will be examined usi…
Phase: PHASE1 • Sponsor: Jennifer Clarke • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could fewer radiation sessions mean fewer complications for sarcoma patients?
Disease control OngoingThis phase II trial studies the wound complication risk of shorter course, hypofractionated pre-surgery radiation therapy in treating patients with localized soft tissue sarcoma of the extremity of superficial trunk that can be removed by surgery. Hypofractionated radiation thera…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart scans may soon replace Needle-Based catheter tests
Diagnosis CompletedThe aim of this study is to evaluate the feasibility of collecting hemodynamic data from right catheterization, all anatomical, functional, flow and substrate determination data under MRI navigation.
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
New drug shows promise in preventing kidney transplant rejection
Disease control CompletedThis study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ rejection in kidney transplant.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart surgery plus ablation: a One-Two punch against stubborn AFib?
Disease control Recruiting nowThe purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF).
Phase: NA • Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC